Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate is a research paper published in Frontiers in Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 83 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 1R01DK121797-01A1
NIGMS NIH HHS
Grant: P20 GM121334
NIDDK NIH HHS
Grant: R01 DK121748
NIDDK NIH HHS
Grant: R01 DK121797
FWCI
5.31
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals